326 related articles for article (PubMed ID: 33754045)
1. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
Taha-Mehlitz S; Bianco G; Coto-Llerena M; Kancherla V; Bantug GR; Gallon J; Ercan C; Panebianco F; Eppenberger-Castori S; von Strauss M; Staubli S; Bolli M; Peterli R; Matter MS; Terracciano LM; von Flüe M; Ng CKY; Soysal SD; Kollmar O; Piscuoglio S
Theranostics; 2021; 11(9):4011-4029. PubMed ID: 33754045
[No Abstract] [Full Text] [Related]
2. Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function.
Jiang T; Sánchez-Rivera FJ; Soto-Feliciano YM; Yang Q; Song CQ; Bhuatkar A; Haynes CM; Hemann MT; Xue W
Hepatology; 2021 Jul; 74(1):233-247. PubMed ID: 33336367
[TBL] [Abstract][Full Text] [Related]
3. Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer.
Zurlo G; Liu X; Takada M; Fan C; Simon JM; Ptacek TS; Rodriguez J; von Kriegsheim A; Liu J; Locasale JW; Robinson A; Zhang J; Holler JM; Kim B; Zikánová M; Bierau J; Xie L; Chen X; Li M; Perou CM; Zhang Q
Nat Commun; 2019 Nov; 10(1):5177. PubMed ID: 31729379
[TBL] [Abstract][Full Text] [Related]
4. Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate.
Park H; Ohshima K; Nojima S; Tahara S; Kurashige M; Hori Y; Okuzaki D; Wada N; Ikeda JI; Morii E
Lab Invest; 2018 Apr; 98(4):449-461. PubMed ID: 29467457
[TBL] [Abstract][Full Text] [Related]
5. DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathway.
García-Moreno JF; Lacerda R; da Costa PJ; Pereira M; Gama-Carvalho M; Matos P; Romão L
Cell Mol Life Sci; 2023 Jun; 80(7):185. PubMed ID: 37340282
[TBL] [Abstract][Full Text] [Related]
6. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
Li Q; Tang H; Hu F; Qin C
J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state.
Zhang WC; Skiados N; Aftab F; Moreno C; Silva L; Corbilla PJA; Asara JM; Hata AN; Slack FJ
Cancer Gene Ther; 2022 Dec; 29(12):1878-1894. PubMed ID: 35840668
[TBL] [Abstract][Full Text] [Related]
8. miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.
Guo X; Zhu Y; Hong X; Zhang M; Qiu X; Wang Z; Qi Z; Hong X
Cell Death Dis; 2017 Jul; 8(7):e2958. PubMed ID: 28749470
[TBL] [Abstract][Full Text] [Related]
9. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.
Sato K; Masuda T; Hu Q; Tobo T; Gillaspie S; Niida A; Thornton M; Kuroda Y; Eguchi H; Nakagawa T; Asano K; Mimori K
EBioMedicine; 2019 Jun; 44():387-402. PubMed ID: 31175057
[TBL] [Abstract][Full Text] [Related]
10. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
11. p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor.
Zhang J; Yang S; Xu B; Wang T; Zheng Y; Liu F; Ren F; Jiang J; Shi H; Zou B; Lu X; Lu S; Dong L
Cell Prolif; 2019 May; 52(3):e12585. PubMed ID: 30793399
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
[No Abstract] [Full Text] [Related]
13. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
15. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
Huang W; Tian Y; Dong S; Cha Y; Li J; Guo X; Yuan X
Oncol Rep; 2017 Sep; 38(3):1402-1410. PubMed ID: 28731158
[TBL] [Abstract][Full Text] [Related]
18. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer.
Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H
Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543
[TBL] [Abstract][Full Text] [Related]
20. Modulating p-AMPK/mTOR Pathway of Mitochondrial Dysfunction Caused by MTERF1 Abnormal Expression in Colorectal Cancer Cells.
Liu Q; Zhang L; Zou Y; Tao Y; Wang B; Li B; Liu R; Wang B; Ding L; Cui Q; Lin J; Mao B; Xiong W; Yu M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
